Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Aug 15;92(17):8021–8025. doi: 10.1073/pnas.92.17.8021

Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine.

A V Ferrer-Montiel 1, W Sun 1, M Montal 1
PMCID: PMC41278  PMID: 7644531

Abstract

The N-methyl-D-aspartate receptor (NMDAR), a pivotal entity for synaptic plasticity and excitotoxicity in the brain, is a target of psychotomimetic drugs such as phencyclidine (PCP) and dizolcipine (MK-801). In contrast, a related glutamate receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate/kainate receptor GluR1, is weakly sensitive to these drugs. Three point mutations on GluR1, mimicking homologous residues on the NMDAR, confer the PCP and MK-801 blockade properties that are characteristic of the NMDAR--namely, high potency, voltage dependence, and use dependence. The molecular determinants that specify the PCP block appear confined to the putative M2 transmembrane segment, whereas the sensitivity to MK-801 requires an interplay between residues from M2 and M3. Given the plausible involvement of the NMDAR in the etiology of several neurodegenerative diseases and in excitotoxic neuronal cell death, tailored glutamate receptors with specific properties may be models for designing and screening new drugs targeted to prevent glutamate-mediated neural damage.

Full text

PDF
8021

Images in this article

8022Fig. 1
on p.8022

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. A., Dingledine R. Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop. Neuron. 1995 Feb;14(2):373–384. doi: 10.1016/0896-6273(95)90293-7. [DOI] [PubMed] [Google Scholar]
  2. Burnashev N., Schoepfer R., Monyer H., Ruppersberg J. P., Günther W., Seeburg P. H., Sakmann B. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science. 1992 Sep 4;257(5075):1415–1419. doi: 10.1126/science.1382314. [DOI] [PubMed] [Google Scholar]
  3. Choi D. W. Bench to bedside: the glutamate connection. Science. 1992 Oct 9;258(5080):241–243. doi: 10.1126/science.1357748. [DOI] [PubMed] [Google Scholar]
  4. Choi D. W., Rothman S. M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13:171–182. doi: 10.1146/annurev.ne.13.030190.001131. [DOI] [PubMed] [Google Scholar]
  5. Collingridge G. L., Lester R. A. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev. 1989 Jun;41(2):143–210. [PubMed] [Google Scholar]
  6. Davies S. N., Alford S. T., Coan E. J., Lester R. A., Collingridge G. L. Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner. Neurosci Lett. 1988 Oct 5;92(2):213–217. doi: 10.1016/0304-3940(88)90063-8. [DOI] [PubMed] [Google Scholar]
  7. Dingledine R., Hume R. I., Heinemann S. F. Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels. J Neurosci. 1992 Oct;12(10):4080–4087. doi: 10.1523/JNEUROSCI.12-10-04080.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Durand G. M., Gregor P., Zheng X., Bennett M. V., Uhl G. R., Zukin R. S. Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9359–9363. doi: 10.1073/pnas.89.19.9359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ferrer-Montiel A. V., Montal M. A negative charge in the M2 transmembrane segment of the neuronal alpha 7 acetylcholine receptor increases permeability to divalent cations. FEBS Lett. 1993 Jun 14;324(2):185–190. doi: 10.1016/0014-5793(93)81390-l. [DOI] [PubMed] [Google Scholar]
  10. Foster A. C., Gill R., Iversen L. L., Kemp J. A., Wong E. H., Woodruff G. N. Therapeutic potential of NMDA receptor antagonists as neuroprotective agents. Prog Clin Biol Res. 1990;361:301–329. [PubMed] [Google Scholar]
  11. Galzi J. L., Devillers-Thiéry A., Hussy N., Bertrand S., Changeux J. P., Bertrand D. Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature. 1992 Oct 8;359(6395):500–505. doi: 10.1038/359500a0. [DOI] [PubMed] [Google Scholar]
  12. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31–108. doi: 10.1146/annurev.ne.17.030194.000335. [DOI] [PubMed] [Google Scholar]
  13. Hollmann M., Maron C., Heinemann S. N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron. 1994 Dec;13(6):1331–1343. doi: 10.1016/0896-6273(94)90419-7. [DOI] [PubMed] [Google Scholar]
  14. Honey C. R., Miljkovic Z., MacDonald J. F. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neurosci Lett. 1985 Oct 24;61(1-2):135–139. doi: 10.1016/0304-3940(85)90414-8. [DOI] [PubMed] [Google Scholar]
  15. Huettner J. E., Bean B. P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1307–1311. doi: 10.1073/pnas.85.4.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem. 1993 Feb 5;268(4):2836–2843. [PubMed] [Google Scholar]
  17. Kozikowski A. P., Pang Y. P. Structural determinants of affinity for the phencyclidine binding site of the N-methyl-D-aspartate receptor complex: discovery of a rigid phencyclidine analogue of high binding affinity. Mol Pharmacol. 1990 Mar;37(3):352–357. [PubMed] [Google Scholar]
  18. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987;154:367–382. doi: 10.1016/0076-6879(87)54085-x. [DOI] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Leeson P. D., Carling R. W., James K., Smith J. D., Moore K. W., Wong E. H., Baker R. Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel. J Med Chem. 1990 May;33(5):1296–1305. doi: 10.1021/jm00167a005. [DOI] [PubMed] [Google Scholar]
  21. Lerma J., Zukin R. S., Bennett M. V. Interaction of Mg2+ and phencyclidine in use-dependent block of NMDA channels. Neurosci Lett. 1991 Feb 25;123(2):187–191. doi: 10.1016/0304-3940(91)90927-l. [DOI] [PubMed] [Google Scholar]
  22. MacDonald J. F., Bartlett M. C., Mody I., Pahapill P., Reynolds J. N., Salter M. W., Schneiderman J. H., Pennefather P. S. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol. 1991 Jan;432:483–508. doi: 10.1113/jphysiol.1991.sp018396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Manallack D. T., Wong M. G., Costa M., Andrews P. R., Beart P. M. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses. Mol Pharmacol. 1988 Dec;34(6):863–879. [PubMed] [Google Scholar]
  24. Masu M., Nakajima Y., Moriyoshi K., Ishii T., Akazawa C., Nakanashi S. Molecular characterization of NMDA and metabotropic glutamate receptors. Ann N Y Acad Sci. 1993 Dec 20;707:153–164. doi: 10.1111/j.1749-6632.1993.tb38050.x. [DOI] [PubMed] [Google Scholar]
  25. Mishina M., Mori H., Araki K., Kushiya E., Meguro H., Kutsuwada T., Kashiwabuchi N., Ikeda K., Nagasawa M., Yamazaki M. Molecular and functional diversity of the NMDA receptor channel. Ann N Y Acad Sci. 1993 Dec 20;707:136–152. doi: 10.1111/j.1749-6632.1993.tb38049.x. [DOI] [PubMed] [Google Scholar]
  26. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P. H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 1992 May 22;256(5060):1217–1221. doi: 10.1126/science.256.5060.1217. [DOI] [PubMed] [Google Scholar]
  27. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 1991 Nov 7;354(6348):31–37. doi: 10.1038/354031a0. [DOI] [PubMed] [Google Scholar]
  28. Nakanishi S., Masu M. Molecular diversity and functions of glutamate receptors. Annu Rev Biophys Biomol Struct. 1994;23:319–348. doi: 10.1146/annurev.bb.23.060194.001535. [DOI] [PubMed] [Google Scholar]
  29. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 1992 Oct 23;258(5082):597–603. doi: 10.1126/science.1329206. [DOI] [PubMed] [Google Scholar]
  30. Olney J. W. Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol. 1990;30:47–71. doi: 10.1146/annurev.pa.30.040190.000403. [DOI] [PubMed] [Google Scholar]
  31. Sakurada K., Masu M., Nakanishi S. Alteration of Ca2+ permeability and sensitivity to Mg2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor. J Biol Chem. 1993 Jan 5;268(1):410–415. [PubMed] [Google Scholar]
  32. Sun W., Ferrer-Montiel A. V., Schinder A. F., McPherson J. P., Evans G. A., Montal M. Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1443–1447. doi: 10.1073/pnas.89.4.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Unwin N. Neurotransmitter action: opening of ligand-gated ion channels. Cell. 1993 Jan;72 (Suppl):31–41. doi: 10.1016/s0092-8674(05)80026-1. [DOI] [PubMed] [Google Scholar]
  34. Wo Z. G., Oswald R. E. Transmembrane topology of two kainate receptor subunits revealed by N-glycosylation. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7154–7158. doi: 10.1073/pnas.91.15.7154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wong E. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Iversen L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104–7108. doi: 10.1073/pnas.83.18.7104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yamakura T., Mori H., Masaki H., Shimoji K., Mishina M. Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. Neuroreport. 1993 Jun;4(6):687–690. doi: 10.1097/00001756-199306000-00021. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES